Product NDC: | 61727-341 |
Proprietary Name: | Influenzinum |
Non Proprietary Name: | Influenzinum 9C |
Active Ingredient(s): | 9; 9 [hp_C]/4g; [hp_C]/4g & nbsp; Influenzinum 9C |
Administration Route(s): | SUBLINGUAL |
Dosage Form(s): | PELLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61727-341 |
Labeler Name: | Homeocare Laboratories |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 20121031 |
Package NDC: | 61727-341-21 |
Package Description: | 4 g in 1 TUBE (61727-341-21) |
NDC Code | 61727-341-21 |
Proprietary Name | Influenzinum |
Package Description | 4 g in 1 TUBE (61727-341-21) |
Product NDC | 61727-341 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Influenzinum 9C |
Dosage Form Name | PELLET |
Route Name | SUBLINGUAL |
Start Marketing Date | 20121031 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | Homeocare Laboratories |
Substance Name | INFLUENZA A VIRUS; INFLUENZA B VIRUS |
Strength Number | 9; 9 |
Strength Unit | [hp_C]/4g; [hp_C]/4g |
Pharmaceutical Classes |